Ulcerative Colitis Market - PowerPoint PPT Presentation

About This Presentation
Title:

Ulcerative Colitis Market

Description:

Ulcerative colitis is a chronic disease that affects the colon of large intestine. It is characterized by inflammation in the large intestine, and the symptoms include blood in the stool, diarrhea and abdominal pain. – PowerPoint PPT presentation

Number of Views:88
Slides: 7
Provided by: ojasdbmr
Category:

less

Transcript and Presenter's Notes

Title: Ulcerative Colitis Market


1
Global Ulcerative Colitis Market Industry
Trends - Forecast to 2026
Global Ulcerative Colitis Market By Type
(Ulcerative Proctitis, Proctosigmoiditis,
Left-Sided Colitis, Pancolitis or Universal
Colitis, and Fulminant Colitis), Drug Type
(Anti-Inflammatory Drugs, Aminosalicylates,
Corticosteroids, Anti-TNF biologics,
Immunosuppressant, Calcineurin Inhibitors,
Other), Molecule type (Small Molecules,
Biologics), Route of Administration (Parentral,
Oral), End- User (Hospital Pharmacies, Retail
Pharmacies, Drug Store, E-commerce)
Browse Full Report and Details TOC
https//www.databridgemarketresearch.com/toc/?dbm
rglobal-ulcerative-colitis-market
2
Report Description
Global ulcerative colitis market is expected to
rise gradually to an estimated value of USD 10.51
billion by 2026, registering a CAGR of 5.4 in
the forecast period of 2019-2026. Ulcerative
colitis is a chronic disease that affects the
colon of large intestine. It is characterized by
inflammation in the large intestine, and the
symptoms include blood in the stool, diarrhea and
abdominal pain.
3
Major Key Players
  • Some of the major players operating in this
    market are
  • Allergan, Inc.
  • AbbVie Inc.
  • Takeda Pharmaceutical Company Limited, Bayer AG
  • UCB S.A.
  • Perrigo Company plc
  • Pfizer Inc.
  • Johnson Johnson Services, Inc.
  • GlaxoSmithKline plc
  • Eli Lilly and Co.
  • Sanofi Aventis A/S

Inquire Before Buying https//www.databridgemark
etresearch.com/inquire-before-buying/?dbmrglobal-
ulcerative-colitis-market
4
Market Segmentation
  • By Type (Ulcerative Proctitis, Proctosigmoiditis,
    Left-Sided Colitis, Pancolitis or Universal
    Colitis, and Fulminant Colitis)
  • By Drug Type (Anti-Inflammatory Drugs,
    Aminosalicylates, Corticosteroids, Anti-TNF
    biologics, Immunosuppressant, Calcineurin
    Inhibitors, Other)
  • By Molecule type (Small Molecules, Biologics)
  • By Route of Administration (Parentral, Oral)
  • By End- User (Hospital Pharmacies, Retail
    Pharmacies, Drug Store, E-commerce)

Get Exclusive Sample Report _at_ https//www.databri
dgemarketresearch.com/request-a-sample/?dbmrgloba
l-ulcerative-colitis-market
5
Regional Analysis
  • Based on geography, the market is segmented into
    five geographical regions
  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East
  • Africa

6
About Data Bridge Market Research
An absolute way to forecast what future holds is
to comprehend the trend today! Data Bridge Market
Research set forth itself as an unconventional
and neoteric Market research and consulting firm
with unparalleled level of resilience and
integrated approaches. We are determined to
unearth  the best market opportunities and foster
efficient information for your business to thrive
in the market. Data Bridge endeavors to provide
appropriate solutions to the complex business
challenges and initiates an effortless
decision-making process. Read Continue
http//databridgemarketresearch.com/about-us/
Contact Us Sopan Gedam Sopan.gedam_at_databridge
marketresearch.com
Write a Comment
User Comments (0)
About PowerShow.com